Essential thrombocythemia proved to be the most frequent myeloproliferative neoplasm, which are findings that align with the premises established by Torres15, who studied a population with BCR::ABL1-negative myeloproliferative neoplasms in the state of Amazonas (Brazil). Here, ABL1 is linked to essential thrombocythemia.